Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy

Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy

Several retrospective and a few prospective studies have shown that metastasis-directed therapy (MDT) could delay clinical progression and postpone the initiation of systemic treatment in oligorecurrent prostate cancer (PCa) patients. However, these endpoints are strongly influenced by variables suc...

Full description

Bibliographic Details
Main Authors: Gaëtan Devos, Charlien Berghen, Henri Van Eecke, Arthur Vander Stichele, Hendrik Van Poppel, Karolien Goffin, Cindy Mai, Liesbeth De Wever, Maarten Albersen, Wouter Everaerts, Gert De Meerleer, Steven Joniau
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Cancers
Subjects:
metastasis directed therapy
oligometastatic prostate cancer
oligorecurrent prostate cancer
metastasectomy
SBRT
salvage lymphadenectomy
Online Access:https://www.mdpi.com/2072-6694/12/8/2271

Internet

https://www.mdpi.com/2072-6694/12/8/2271

Similar Items